Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ebrima Kanteh
Observed name:
Ebrima K. Kanteh
Institutions:
London School of Hygiene & Tropical Medicine,
MRC Unit the Gambia,
Medical Research Council
Observed institutions:
London School of Hygiene & Tropical Medicine,
MRC Unit the Gambia,
Medical Research Council
ORCID:
0000-0003-3558-2517
Observed ORCID:
0000-0003-3558-2517
OpenAlex ID:
A5007209892
Enhanced postoperative surveillance versus standard of care to reduce mortality among adult surgical patients in Africa (ASOS-2): a cluster-randomised controlled trial
2021
·
Bruce M Biccard
, Leon du Toit
, et al.
·
The Lancet Global Health
·
77
PDF
An assessment of critical care capacity in the Gambia
2018
·
Sunkaru Touray
, Baboucarr Sanyang
, et al.
·
Journal of Critical Care
·
39
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
2017
·
Victorine A. Mensah
, Sophie Roetynck
, et al.
·
Frontiers in Immunology
·
31
PDF
Understanding the performance of a pan-African intervention to reduce postoperative mortality: a mixed-methods process evaluation of the ASOS-2 trial
2021
·
Nicola Vickery
, Timothy Stephens
, et al.
·
British Journal of Anaesthesia
·
14
PDF
The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial
2025
·
Anja Saso
, Ebrima Kanteh
, et al.
·
The Lancet Infectious Diseases
·
12
Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages
2024
·
Beate Kampmann
, Caitlin Pley
, et al.
·
Wellcome Open Research
·
4
The impact of acellular pertussis vaccination in pregnancy on the immunogenicity of acellular versus whole-cell pertussis vaccines in infancy: A protocol for a phase IV randomised, controlled mother-infant pertussis vaccine trial (The Gambian Pertussis Study, GaPs)
2024
·
Anja Saso
, Sophie Roetynck
, et al.
·
Wellcome Open Research
·
3
Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial
2026
·
Anja Saso
, Janeri Fröberg
, et al.
·
The Lancet Microbe
·
2
PDF
AI-Assisted Multilingual Pedagogy in Computing Education: A Culturo-Techno-Contextual Approach Framework for Enhancing Achievement and Attitudinal Outcomes in Mobile and Adaptive Systems
2026
·
Alli Abdurrazaq
, Omar Camara
, et al.
·
Elicit Journal of Education Studies
PDF
Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trial
2026
·
Caitlin Pley
, David J Jeffries
, et al.
·
The Lancet Infectious Diseases
Long‑Term Cellular Responses to Primary Yellow Fever 17D Vaccination and the Effect of a Booster Dose in Children in The Gambia
2026
·
Julia Strandmark
, Aru Kumba Baldeh
, et al.
·
SSRN Electronic Journal
Immunogenicity of Malaria-vectored Vaccines Is Not Affected by Co-administration With Routine Epi Vaccines in a Randomised Controlled Trial in Gambian Infants and Neonates
2017
·
Muhammed Afolabi
, Victorine Mensah
, et al.
·
BMJ Global Health
PDF
Show more works
View as search
Works count:
12
Citation count:
182
H-index:
5
I10-index:
5
Year
Topic
Type